At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
In this expert Q&A, Mats Enlund, MD, PhD, discusses his team's study that adds to the growing literature on the impact of general anesthesia choice on overall survival among patients undergoing breast...
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
